Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

rondi7 | 4 points | Dec 31 2020 23:06:21

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

This from AAPS, and lots of names have contributed to this. It is an update of previously written by Peter McCoullough.

https://aapsonline.us1.list-manage.com/track/click?u=30a32513ae04f5445c95f3239&id=2e7a1d7fe2&e=6ab1c025ae

While not specific to IVM, this is the only Reddit I know which is concerned with home treatment. If there is another one--please copy the link there.

[-] akaariai | 1 points | Jan 01 2021 07:13:23

Their take on ivm is interesting:

Hence, it is reasonable in patients where HCQ cannot be used and favipiravir is not available, that IVM (200-600 mcg/kg [6-36 mg] single oral dose given daily or every other day for 2- 3 administrations) could be the base of SMDT intended to reduce viral replication early in the course of COVID-19.

So, use only early in the disease, also hcq and favipiravir are superior choises.

They are basing the recommendation solely on antiviral effect which isn't the whole picture of ivm.